Try the Demo today!
| SEC Filing | Insider | Company | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Return |
|---|---|---|---|---|---|---|---|---|---|
| 02-Apr-24 8:35 PM View:  | Cittadine Andrew Chief Operating Officer | Monopar Therapeutics (MNPR) | 31-Mar-24 | Option Exercise | 8,952 | -- | -- | 17% 51.77K to 60.72K | |
| 02-Apr-24 8:33 PM View: | Tsuchimoto Kim R Chief Financial Officer Director | Monopar Therapeutics (MNPR) | 31-Mar-24 | Option Exercise | 9,956 | -- | -- | 22% 44.6K to 54.55K | |
| 02-Apr-24 8:33 PM View: | Robinson Chandler Chief Executive Officer Director | Monopar Therapeutics (MNPR) | 31-Mar-24 | Payment of Exercise | 7,172 | $0.68 | $4,884.13 | (< 1%) 4.45M to 4.44M | |
| 02-Apr-24 8:33 PM View: | Robinson Chandler Chief Executive Officer Director | Monopar Therapeutics (MNPR) | 31-Mar-24 | Option Exercise | 24,474 | -- | -- | < 1% 4.43M to 4.45M | |
| 02-Apr-24 8:35 PM View: | Cittadine Andrew Chief Operating Officer | Monopar Therapeutics (MNPR) | 31-Mar-24 | Payment of Exercise | 3,098 | $0.68 | $2,109.74 | (5%) 60.72K to 57.62K | |
| 02-Apr-24 8:33 PM View: | Tsuchimoto Kim R Chief Financial Officer Director | Monopar Therapeutics (MNPR) | 31-Mar-24 | Payment of Exercise | 4,082 | $0.68 | $2,779.84 | (7%) 54.55K to 50.47K | |
| 03-Jan-24 7:36 PM View: | Robinson Chandler Chief Executive Officer Director | Monopar Therapeutics (MNPR) | 01-Jan-24 | Option Exercise | 6,724 | -- | -- | < 1% 4.42M to 4.43M | |
| 03-Jan-24 7:36 PM View: | Robinson Chandler Chief Executive Officer Director | Monopar Therapeutics (MNPR) | 01-Jan-24 | Payment of Exercise | 2,327 | $0.34 | $791.65 | (< 1%) 4.43M to 4.43M | |
| 03-Jan-24 7:34 PM View: | Tsuchimoto Kim R Chief Financial Officer Director | Monopar Therapeutics (MNPR) | 01-Jan-24 | Option Exercise | 1,231 | -- | -- | 3% 43.87K to 45.1K | |
| 03-Jan-24 7:34 PM View: | Tsuchimoto Kim R Chief Financial Officer Director | Monopar Therapeutics (MNPR) | 01-Jan-24 | Payment of Exercise | 505 | $0.34 | $171.80 | (1%) 45.1K to 44.6K | |
| 03-Jan-24 7:39 PM View: | Cittadine Andrew Chief Operating Officer | Monopar Therapeutics (MNPR) | 31-Dec-23 | Payment of Exercise | 3,098 | $0.34 | $1,053.94 | (6%) 54.87K to 51.77K | |
| 03-Jan-24 7:34 PM View: | Tsuchimoto Kim R Chief Financial Officer Director | Monopar Therapeutics (MNPR) | 31-Dec-23 | Option Exercise | 9,957 | -- | -- | 26% 37.99K to 47.94K | |
| 03-Jan-24 7:39 PM View: | Cittadine Andrew Chief Operating Officer | Monopar Therapeutics (MNPR) | 31-Dec-23 | Option Exercise | 8,952 | -- | -- | 19% 45.92K to 54.87K | |
| 03-Jan-24 7:34 PM View: | Tsuchimoto Kim R Chief Financial Officer Director | Monopar Therapeutics (MNPR) | 31-Dec-23 | Payment of Exercise | 4,073 | $0.34 | $1,385.63 | (8%) 47.94K to 43.87K | |
| 03-Jan-24 7:38 PM View: | Klausner Arthur J Director | Monopar Therapeutics (MNPR) | 31-Dec-23 | Option Exercise | 2,533 | -- | -- | < 1% 3.08M to 3.09M | |
| 03-Jan-24 7:36 PM View: | Robinson Chandler Chief Executive Officer Director | Monopar Therapeutics (MNPR) | 31-Dec-23 | Option Exercise | 24,474 | -- | -- | < 1% 4.41M to 4.43M | |
| 03-Jan-24 7:37 PM View: | Starr Christopher M Director | Monopar Therapeutics (MNPR) | 31-Dec-23 | Option Exercise | 2,533 | -- | -- | 3% 72.73K to 75.26K | |
| 03-Jan-24 7:40 PM View: | Brown Michael J Director | Monopar Therapeutics (MNPR) | 31-Dec-23 | Option Exercise | 2,533 | -- | -- | < 1% 4.51M to 4.51M | |
| 03-Jan-24 7:40 PM View: | Anderson Raymond Director | Monopar Therapeutics (MNPR) | 31-Dec-23 | Option Exercise | 2,533 | -- | -- | 10% 24.33K to 26.86K | |
| 03-Jan-24 7:36 PM View: | Robinson Chandler Chief Executive Officer Director | Monopar Therapeutics (MNPR) | 31-Dec-23 | Payment of Exercise | 8,469 | $0.34 | $2,881.15 | (< 1%) 4.43M to 4.42M | |
| 03-Oct-23 10:00 PM View: | Tsuchimoto Kim R Chief Financial Officer Director | Monopar Therapeutics (MNPR) | 30-Sep-23 | Option Exercise | 9,956 | -- | -- | 32% 31.47K to 41.43K | |
| 03-Oct-23 10:00 PM View: | Klausner Arthur J Director | Monopar Therapeutics (MNPR) | 30-Sep-23 | Option Exercise | 2,533 | -- | -- | < 1% 3.08M to 3.08M | |
| 03-Oct-23 10:00 PM View: | Tsuchimoto Kim R Chief Financial Officer Director | Monopar Therapeutics (MNPR) | 30-Sep-23 | Payment of Exercise | 3,444 | $0.62 | $2,134.94 | (8%) 41.43K to 37.99K | |
| 03-Oct-23 10:00 PM View: | Starr Christopher M Director | Monopar Therapeutics (MNPR) | 30-Sep-23 | Option Exercise | 2,533 | -- | -- | 4% 70.2K to 72.73K | |
| 03-Oct-23 10:00 PM View: | Brown Michael J Director | Monopar Therapeutics (MNPR) | 30-Sep-23 | Option Exercise | 2,533 | -- | -- | < 1% 4.51M to 4.51M | |
| 03-Oct-23 10:00 PM View: | Anderson Raymond Director | Monopar Therapeutics (MNPR) | 30-Sep-23 | Option Exercise | 2,533 | -- | -- | 12% 21.8K to 24.33K | |
| 03-Oct-23 10:00 PM View: | Robinson Chandler Chief Executive Officer Director | Monopar Therapeutics (MNPR) | 30-Sep-23 | Option Exercise | 24,474 | -- | -- | < 1% 4.39M to 4.41M | |
| 03-Oct-23 10:00 PM View: | Cittadine Andrew Chief Operating Officer | Monopar Therapeutics (MNPR) | 30-Sep-23 | Option Exercise | 8,953 | -- | -- | 23% 39.59K to 48.54K | |
| 03-Oct-23 10:00 PM View: | Robinson Chandler Chief Executive Officer Director | Monopar Therapeutics (MNPR) | 30-Sep-23 | Payment of Exercise | 7,172 | $0.62 | $4,445.92 | (< 1%) 4.41M to 4.41M | |
| 03-Oct-23 10:00 PM View: | Cittadine Andrew Chief Operating Officer | Monopar Therapeutics (MNPR) | 30-Sep-23 | Payment of Exercise | 2,624 | $0.62 | $1,626.62 | (5%) 48.54K to 45.92K | |
| 03-Jul-23 6:46 PM View: | Tsuchimoto Kim R Chief Financial Officer Director | Monopar Therapeutics (MNPR) | 30-Jun-23 | Payment of Exercise | 5,104 | $0.86 | $4,363.92 | (14%) 36.58K to 31.47K | |
| 03-Jul-23 6:46 PM View: | Starr Christopher M Director | Monopar Therapeutics (MNPR) | 30-Jun-23 | Option Exercise | 2,534 | -- | -- | 4% 67.66K to 70.2K | |
| 03-Jul-23 6:49 PM View: | Brown Michael J Director | Monopar Therapeutics (MNPR) | 30-Jun-23 | Option Exercise | 2,534 | -- | -- | < 1% 4.51M to 4.51M | |
| 03-Jul-23 6:50 PM View: | Anderson Raymond Director | Monopar Therapeutics (MNPR) | 30-Jun-23 | Option Exercise | 2,534 | -- | -- | 13% 19.26K to 21.8K | |
| 03-Jul-23 6:45 PM View: | Robinson Chandler Chief Executive Officer Director | Monopar Therapeutics (MNPR) | 30-Jun-23 | Option Exercise | 35,039 | -- | -- | < 1% 4.36M to 4.4M | |
| 03-Jul-23 6:51 PM View: | Cittadine Andrew Chief Operating Officer | Monopar Therapeutics (MNPR) | 30-Jun-23 | Option Exercise | 13,841 | -- | -- | 46% 29.8K to 43.64K | |
| 03-Jul-23 6:45 PM View: | Robinson Chandler Chief Executive Officer Director | Monopar Therapeutics (MNPR) | 30-Jun-23 | Payment of Exercise | 10,269 | $0.86 | $8,780.00 | (< 1%) 4.4M to 4.39M | |
| 03-Jul-23 6:51 PM View: | Cittadine Andrew Chief Operating Officer | Monopar Therapeutics (MNPR) | 30-Jun-23 | Payment of Exercise | 4,057 | $0.86 | $3,468.74 | (9%) 43.64K to 39.59K | |
| 03-Jul-23 6:46 PM View: | Tsuchimoto Kim R Chief Financial Officer Director | Monopar Therapeutics (MNPR) | 30-Jun-23 | Option Exercise | 14,846 | -- | -- | 68% 21.73K to 36.58K | |
| 03-Jul-23 6:49 PM View: | Klausner Arthur J Director | Monopar Therapeutics (MNPR) | 30-Jun-23 | Option Exercise | 2,534 | -- | -- | < 1% 3.08M to 3.08M | |
| 04-Apr-23 5:15 PM View: | Cittadine Andrew Chief Operating Officer | Monopar Therapeutics (MNPR) | 31-Mar-23 | Payment of Exercise | 1,154 | $1.39 | $1,604.06 | (4%) 30.96K to 29.8K | |
| 04-Apr-23 5:17 PM View: | Robinson Chandler Chief Executive Officer Director | Monopar Therapeutics (MNPR) | 31-Mar-23 | Option Exercise | 13,911 | -- | -- | < 1% 4.35M to 4.37M | |
| 04-Apr-23 5:16 PM View: | Tsuchimoto Kim R Chief Financial Officer Director | Monopar Therapeutics (MNPR) | 31-Mar-23 | Payment of Exercise | 1,842 | $1.39 | $2,560.38 | (8%) 23.57K to 21.73K | |
| 04-Apr-23 5:17 PM View: | Robinson Chandler Chief Executive Officer Director | Monopar Therapeutics (MNPR) | 31-Mar-23 | Payment of Exercise | 4,286 | $1.39 | $5,957.54 | (< 1%) 4.37M to 4.36M | |
| 04-Apr-23 5:15 PM View: | Cittadine Andrew Chief Operating Officer | Monopar Therapeutics (MNPR) | 31-Mar-23 | Option Exercise | 4,063 | -- | -- | 15% 26.89K to 30.96K | |
| 04-Apr-23 5:20 PM View: | Klausner Arthur J Director | Monopar Therapeutics (MNPR) | 31-Mar-23 | Option Exercise | 2,533 | -- | -- | < 1% 3.08M to 3.08M | |
| 04-Apr-23 5:16 PM View: | Tsuchimoto Kim R Chief Financial Officer Director | Monopar Therapeutics (MNPR) | 31-Mar-23 | Option Exercise | 5,067 | -- | -- | 27% 18.51K to 23.57K | |
| 04-Apr-23 5:21 PM View: | Starr Christopher M Director | Monopar Therapeutics (MNPR) | 31-Mar-23 | Option Exercise | 2,533 | -- | -- | 4% 65.13K to 67.66K | |
| 04-Apr-23 5:19 PM View: | Brown Michael J Director | Monopar Therapeutics (MNPR) | 31-Mar-23 | Option Exercise | 2,533 | -- | -- | < 1% 4.5M to 4.51M | |
| 04-Apr-23 5:18 PM View: | Anderson Raymond Director | Monopar Therapeutics (MNPR) | 31-Mar-23 | Option Exercise | 2,533 | -- | -- | 15% 16.73K to 19.26K |
